Rifampin labels and packages: Difference between revisions
Jump to navigation
Jump to search
(Created page with "__NOTOC__ {{Rifampin }} {{CMG}}; {{AE}} {{chetan}} <ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = RIFADIN (RIFAMPIN) CAPSULE RIFADIN IV (RIFA...") |
No edit summary |
||
| (One intermediate revision by the same user not shown) | |||
| Line 3: | Line 3: | ||
{{CMG}}; {{AE}} {{chetan}} | {{CMG}}; {{AE}} {{chetan}} | ||
==Labels And Packages== | |||
PRINCIPAL DISPLAY PANEL - 150mg Bottle Label | |||
NDC 0068-0510-30 | |||
Rifadin® | |||
150mg | |||
rifampin capsules USP | |||
30 Capsules | |||
sanofi aventis | |||
{| | |||
|- | |||
| [[File:RIFADIN8.jpg|800px|thumb]] | |||
|- | |||
|} | |||
PRINCIPAL DISPLAY PANEL - 600mg Vial Carton | |||
NDC 0068-0597-01 | |||
Rifadin® | |||
IV | |||
rifampin for | |||
injection | |||
USP | |||
600mg | |||
For IV | |||
Infusion Only | |||
1 Sterile Vial | |||
sanofi aventis <ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = RIFADIN (RIFAMPIN) CAPSULE RIFADIN IV (RIFAMPIN) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [SANOFI-AVENTIS U.S. LLC] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=036ab68e-5085-4edc-bd83-784b43d64eab | publisher = | date = | accessdate = }}</ref> | |||
{| | |||
|- | |||
| [[File:RIFADIN9.jpg|800px|thumb]] | |||
|- | |||
|} | |||
Latest revision as of 23:57, 5 January 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Chetan Lokhande, M.B.B.S [2]
Labels And Packages
PRINCIPAL DISPLAY PANEL - 150mg Bottle Label
NDC 0068-0510-30 Rifadin® 150mg rifampin capsules USP 30 Capsules sanofi aventis
 |
PRINCIPAL DISPLAY PANEL - 600mg Vial Carton
NDC 0068-0597-01 Rifadin® IV rifampin for injection USP 600mg For IV Infusion Only 1 Sterile Vial sanofi aventis [1]
 |
References
Adapted from the FDA Package Insert.